📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. (2018)

First Author: Baud MGJ

Attributed to: Structural biology of the tumour suppressor p53 and its complexes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2018.04.035

PubMed Identifier: 29702446

Publication URI: http://europepmc.org/abstract/MED/29702446

Type: Journal Article/Review

Volume: 152

Parent Publication: European journal of medicinal chemistry

ISSN: 0223-5234